Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaoshi Wu

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Applied Statistics|September 13, 2024
Interval-specific censoring set adjusted Kaplan-Meier estimatorYaoshi Wu, John Kolassa
Pharmaceutical Statistics|June 24, 2020
Empirical profile Bayesian estimation for extrapolation of historical adult data to pediatric drug developmentYaoshi Wu, Jianan Hui, Qiqi Deng
Contemporary Clinical Trials|March 22, 2025
Restricted mean survival time based on Wu-Kolassa estimator compared to Kaplan-Meier estimatorYaoshi Wu, John Kolassa, Ning Dong
Pharmaceutical Statistics|November 23, 2022
Sample size re-estimation in Phase 2 dose-finding: Conditional power versus Bayesian predictive powerQingyang Liu, Guanyu Hu, Binqi Ye, et al.
American Journal of Cancer Research|December 2, 2016
MicroRNA-133a-3p exerts inhibitory effects on gallbladder carcinoma via targeting RBPJYuan Huang, Yaoshi Wu, Jiahong Dong, et al.
The Journal of Antimicrobial Chemotherapy|June 30, 2011
Determination of rifabutin dosing regimen when administered in combination with ritonavir-boosted atazanavirJenny Zhang, Li Zhu, Michele Stonier, et al.
AIDS Patient Care and Stds|July 21, 2011
Effects of the H2-receptor antagonist famotidine on the pharmacokinetics of atazanavir-ritonavir with or without tenofovir in HIV-infected patientsXiaodong Wang, Marta Boffito, Jenny Zhang, et al.
Molecular Genetics and Metabolism|January 24, 2018
Once- versus twice-daily dosing of eliglustat in adults with Gaucher disease type 1: The Phase 3, randomized, double-blind EDGE trialJoel Charrow, Cristina Fraga, Xuefan Gu, et al.
Cancer Letters|March 8, 2016
A novel PI3K/AKT signaling axis mediates Nectin-4-induced gallbladder cancer cell proliferation, metastasis and tumor growthYijian Zhang, Shibo Liu, Lei Wang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Applied Statistics|September 13, 2024
Interval-specific censoring set adjusted Kaplan-Meier estimatorYaoshi Wu, John Kolassa
Pharmaceutical Statistics|June 24, 2020
Empirical profile Bayesian estimation for extrapolation of historical adult data to pediatric drug developmentYaoshi Wu, Jianan Hui, Qiqi Deng
Contemporary Clinical Trials|March 22, 2025
Restricted mean survival time based on Wu-Kolassa estimator compared to Kaplan-Meier estimatorYaoshi Wu, John Kolassa, Ning Dong
Pharmaceutical Statistics|November 23, 2022
Sample size re-estimation in Phase 2 dose-finding: Conditional power versus Bayesian predictive powerQingyang Liu, Guanyu Hu, Binqi Ye, et al.
American Journal of Cancer Research|December 2, 2016
MicroRNA-133a-3p exerts inhibitory effects on gallbladder carcinoma via targeting RBPJYuan Huang, Yaoshi Wu, Jiahong Dong, et al.
The Journal of Antimicrobial Chemotherapy|June 30, 2011
Determination of rifabutin dosing regimen when administered in combination with ritonavir-boosted atazanavirJenny Zhang, Li Zhu, Michele Stonier, et al.
AIDS Patient Care and Stds|July 21, 2011
Effects of the H2-receptor antagonist famotidine on the pharmacokinetics of atazanavir-ritonavir with or without tenofovir in HIV-infected patientsXiaodong Wang, Marta Boffito, Jenny Zhang, et al.
Molecular Genetics and Metabolism|January 24, 2018
Once- versus twice-daily dosing of eliglustat in adults with Gaucher disease type 1: The Phase 3, randomized, double-blind EDGE trialJoel Charrow, Cristina Fraga, Xuefan Gu, et al.
Cancer Letters|March 8, 2016
A novel PI3K/AKT signaling axis mediates Nectin-4-induced gallbladder cancer cell proliferation, metastasis and tumor growthYijian Zhang, Shibo Liu, Lei Wang, et al.
Pageof 1